151 related articles for article (PubMed ID: 27421789)
1. Effect of subacute agomelatine treatment on painful diabetic neuropathy: involvement of catecholaminergic mechanisms.
Aydın TH; Can ÖD; Demir Özkay Ü; Turan N
Fundam Clin Pharmacol; 2016 Dec; 30(6):549-567. PubMed ID: 27421789
[TBL] [Abstract][Full Text] [Related]
2. Antihyperalgesic and antiallodynic effects of mianserin on diabetic neuropathic pain: a study on mechanism of action.
Üçel Uİ; Can ÖD; Demir Özkay Ü; Öztürk Y
Eur J Pharmacol; 2015 Jun; 756():92-106. PubMed ID: 25771454
[TBL] [Abstract][Full Text] [Related]
3. Catecholaminergic and opioidergic system mediated effects of reboxetine on diabetic neuropathic pain.
Turan Yücel N; Can ÖD; Demir Özkay Ü
Psychopharmacology (Berl); 2020 Apr; 237(4):1131-1145. PubMed ID: 31912189
[TBL] [Abstract][Full Text] [Related]
4. Antihyperalgesic Activity of Atomoxetine on Diabetes-Induced Neuropathic Pain: Contribution of Noradrenergic and Dopaminergic Systems.
Barbaros MB; Can ÖD; Üçel Uİ; Turan Yücel N; Demir Özkay Ü
Molecules; 2018 Aug; 23(8):. PubMed ID: 30126223
[TBL] [Abstract][Full Text] [Related]
5. Clavulanic Acid Attenuating Effect on the Diabetic Neuropathic Pain in Rats.
Kolahdouz M; Jafari F; Falanji F; Nazemi S; Mohammadzadeh M; Molavi M; Amin B
Neurochem Res; 2021 Jul; 46(7):1759-1770. PubMed ID: 33846883
[TBL] [Abstract][Full Text] [Related]
6. Agomelatine: a new opportunity to reduce neuropathic pain-preclinical evidence.
Chenaf C; Chapuy E; Libert F; Marchand F; Courteix C; Bertrand M; Gabriel C; Mocaër E; Eschalier A; Authier N
Pain; 2017 Jan; 158(1):149-160. PubMed ID: 27984527
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological characterization of different fractions of Calotropis procera (Asclepiadaceae) in streptozotocin induced experimental model of diabetic neuropathy.
Yadav SK; Nagori BP; Desai PK
J Ethnopharmacol; 2014 Mar; 152(2):349-57. PubMed ID: 24486599
[TBL] [Abstract][Full Text] [Related]
8. Antinociceptive effects of fisetin against diabetic neuropathic pain in mice: Engagement of antioxidant mechanisms and spinal GABAA receptors.
Zhao X; Li XL; Liu X; Wang C; Zhou DS; Ma Q; Zhou WH; Hu ZY
Pharmacol Res; 2015 Dec; 102():286-97. PubMed ID: 26520392
[TBL] [Abstract][Full Text] [Related]
9. Antinociceptive, antiallodynic and antihyperalgesic effects of the 5-HT
Sałat K; Kołaczkowski M; Furgała A; Rojek A; Śniecikowska J; Varney MA; Newman-Tancredi A
Neuropharmacology; 2017 Oct; 125():181-188. PubMed ID: 28751195
[TBL] [Abstract][Full Text] [Related]
10. Emblica officinalis corrects functional, biochemical and molecular deficits in experimental diabetic neuropathy by targeting the oxido-nitrosative stress mediated inflammatory cascade.
Tiwari V; Kuhad A; Chopra K
Phytother Res; 2011 Oct; 25(10):1527-36. PubMed ID: 21394805
[TBL] [Abstract][Full Text] [Related]
11. Magnesium attenuates chronic hypersensitivity and spinal cord NMDA receptor phosphorylation in a rat model of diabetic neuropathic pain.
Rondón LJ; Privat AM; Daulhac L; Davin N; Mazur A; Fialip J; Eschalier A; Courteix C
J Physiol; 2010 Nov; 588(Pt 21):4205-15. PubMed ID: 20837644
[TBL] [Abstract][Full Text] [Related]
12. Antineuropathic effect of 7-hydroxy-3,4-dihydrocadalin in streptozotocin-induced diabetic rodents.
Rocha-González HI; Ramírez-Aguilar M; Granados-Soto V; Reyes-García JG; Torres-López JE; Huerta-Cruz JC; Navarrete A
BMC Complement Altern Med; 2014 Apr; 14():129. PubMed ID: 24708659
[TBL] [Abstract][Full Text] [Related]
13. Neuroprotective effect of naringin by modulation of endogenous biomarkers in streptozotocin induced painful diabetic neuropathy.
Kandhare AD; Raygude KS; Ghosh P; Ghule AE; Bodhankar SL
Fitoterapia; 2012 Jun; 83(4):650-9. PubMed ID: 22343014
[TBL] [Abstract][Full Text] [Related]
14. Isobolographic Analyses of Proglumide-Celecoxib Interaction in Rats with Painful Diabetic Neuropathy.
Suarez-Mendez S; Tovilla-Zarate CA; Ortega-Varela LF; Bermudez-Ocaña DY; Blé-Castillo JL; González-Castro TB; Zetina-Esquivel AM; Diaz-Zagoya JC; Esther Juárez-Rojop I
Drug Dev Res; 2017 Mar; 78(2):116-123. PubMed ID: 28370133
[TBL] [Abstract][Full Text] [Related]
15. Long-term administration of fluvoxamine attenuates neuropathic pain and involvement of spinal serotonin receptors in diabetic model rats.
Kato T; Kajiyama S; Hamada H; Kawamoto M
Hiroshima J Med Sci; 2013 Dec; 62(4):83-9. PubMed ID: 24597211
[TBL] [Abstract][Full Text] [Related]
16. Comparison of actions of systemically and locally administrated local anaesthetics in diabetic rats with painful neuropathy.
Mert T; Gunes Y; Gunay I
Fundam Clin Pharmacol; 2013 Apr; 27(2):161-8. PubMed ID: 21985706
[TBL] [Abstract][Full Text] [Related]
17. The role of spinal serotonin receptor and alpha adrenoceptor on the antiallodynic effects induced by intrathecal milnacipran in chronic constriction injury rats.
Nakamura T; Ikeda T; Takeda R; Igawa K; Naono-Nakayama R; Sakoda S; Nishimori T; Ishida Y
Eur J Pharmacol; 2014 Sep; 738():57-65. PubMed ID: 24876059
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effect of Ligustrum vulgare leaf extract on the development of neuropathic pain in a streptozotocin-induced rat model of diabetes.
Czerwińska ME; Gąsińska E; Leśniak A; Krawczyk P; Kiss AK; Naruszewicz M; Bujalska-Zadrożny M
Phytomedicine; 2018 Oct; 49():75-82. PubMed ID: 30217264
[TBL] [Abstract][Full Text] [Related]
19. Bradykinin receptors antagonists and nitric oxide synthase inhibitors in vincristine and streptozotocin induced hyperalgesia in chemotherapy and diabetic neuropathy rat model.
Bujalska M; Makulska-Nowak H
Neuro Endocrinol Lett; 2009 Mar; 30(1):144-52. PubMed ID: 19300402
[TBL] [Abstract][Full Text] [Related]
20. L-Arginine supplementation prevents allodynia and hyperalgesia in painful diabetic neuropathic rats by normalizing plasma nitric oxide concentration and increasing plasma agmatine concentration.
Rondón LJ; Farges MC; Davin N; Sion B; Privat AM; Vasson MP; Eschalier A; Courteix C
Eur J Nutr; 2018 Oct; 57(7):2353-2363. PubMed ID: 28725942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
